Subsequent Events

3 Months Ended

Oct. 31, 2015

Subsequent Events [Abstract]

Subsequent Events

7. Subsequent Events 

In November 2015, the Company issued 14,327 shares of common stock upon the execution of a binding letter of intent to agree to negotiate and enter into an exclusive license agreement and collaboration agreement with a pharmaceutical company with certain desirable proprietary information. Pursuant to the letter of intent, the Company is obligated to issue up to an additional 92,634 common shares upon the occurrence of various milestones.